Enniatin B1 is a substrate of intestinal P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein

World Mycotoxin Journal

Volumn 3, Issue 3, 2010, Pages 271-281

  Ivanova, L ^a   Uhlig, S ^a   Eriksen, G S ^a   Johannessen, L E ^a  

^a NORWEGIAN VETERINARY INSTITUTE   (Norway)

Author keywords

ABC transporters; Caco 2 cells; Intestinal absorption

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; ENNIATIN; FUMITREMORGIN C; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2; VERAPAMIL; VERLUKAST;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MEMBRANE PERMEABILITY; PROTEIN ANALYSIS; PROTEIN TRANSPORT;

EID: 77955694673     PISSN: 18750710     EISSN: 18750796     Source Type: Journal    
DOI: 10.3920/WMJ2010.1225     Document Type: Article

References (59)

1. Artursson, P., Palm, K. and Luthman, K., 2001. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews 46: 27-43. (Pubitemid 33653412)
2. Berger, V., Gabriel, A.F., Sergent, T., Trouet, A., Larondelle, Y. and Schneider, Y.J., 2003. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicology Letters 140- 141: 465-476.
3. Blais, L.A., Apsimon, J.W., Blackwell, B.A., Greenhalgh, R. and Miller, J.D., 1992. Isolation and characterization of enniatins from Fusarium avenaceum Daom-196490. Canadian Journal of Chemistry 70: 1281-1287.
4. Boulenc, X., 1997. Intestinal cell models. Their use in evaluating the metabolism and absorption of xenobiotics. STP Pharma Sciences 7: 259-269.
5. Burmeister, H.R. and Plattner, R.D., 1987. Enniatin production by Fusarium tricinctum and its effect on germinating wheat seeds. Physiology and Biochemistry 77: 1483-1487
6. Chan, L.M.S, Lowes, S. and Hirst, B.H., 2004. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. European Journal of Pharmaceutical Sciences 21: 25-51.
7. De Angelis, I., Frigge, G., Raimondi, F., Stammati, A., Zucco, F. and Caloni, F., 2005. Absorption of fumonisin B1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein. Toxicon 45: 285-291. (Pubitemid 40431272)
8. Del Amo, E.M., Heikkinen, A.T. and Mönkkönen, J., 2009. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption. European Journal of Pharmaceutical Sciences 36: 200-211.
9. Dornetshuber, R., Heffeter, P., Kamyar, M.R., Peterbauer, T., Berger, W. and Lemmens-Gruber, R., 2007. Enniatins exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells. Chemical Research in Toxicology 20: 465-473.
10. Dornetshuber, R., Heffeter, P., Sulyok, M., Schumacher, R., Chiba, P., Kopp, S., Koellensperger, G., Micksche, M., Lemmens-Gruber, R. and Berger, W., 2009. Interactions between ABC-transport proteins and the secondary Fusarium metabolites enniatin and beauvericin. Molecular Nutrition & Food Research 53: 904-920.
11. Drewe, J., Gutmann, H., Fricker, G., Török, M., Beglinger, C. and Huwyler, J., 1999. HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochemical Pharmacology 57: 1147-1152.
12. Evers, R., Cnubben, N.H., Wijnholds, J., Van Deemter, L., Van Bladeren, P.J. and Borst, P., 1997. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Letters 419: 112-116.
13. Evers, R., Kool, M., Van Deemter, L., Janssen, H., Calafat, J., Ooomen, L.C., Paulusma, C.C., Oude Elferink, R.P., Baas, F., Schinkel A.H. and Borst P., 1998. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. The Journal of Clinical Investigation 101: 1310-1319.
14. Evseenko, D.A., Paxton, J.W. and Keelan, J.A., 2006. ABC drug transporter expression and functional activity in trophoblast-like cell line and differentiating primary trophoblast. The American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 290: R1357-R1365.
15. Ford, J.M., 1996. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. European Journal of Cancer 32A: 991-1001.
16. Fornelli, F., Minervini, F. and Logrieco, A., 2004. Cytotoxicity of fungal metabolites to lepidopteran (Spodoptera frugiperda) cell line (SF-9). Journal of Invertebrate Pathology 85: 74-79.
17. Fromm, M.F., 2003. Importance of P-glycoprotein for drug disposition in humans. European Journal of Clinical Investigation 33, Suppl. 2: 6-9.
18. Gan, L.S. and Thakker, D.R., 1997. Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium. Advanced Drug Delivery Reviews 23: 77-98.
19. Gekeler, V., Ise, W., Sanders, K.H., Ulrich, W.R. and Beck, J., 1995. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochemical and Biophysical Research Communications 208: 345-352.
20. Gäumann, E., Naef-Roth, S. and Kern, H., 1960. Zur phytotoxischen wirkung der Enniatine. Phytopathologische Zeitschrift 40: 45-51.
21. Gäumann, E., Roth, S., Etlinger, L., Plattner, P.A. and Nager, U., 1947. Enniatin, ein neues, gegen Mykobakterien wirksames Antibiotikum. Experientia 3: 202.
22. Goh, L.B., Spears, K.J., Yao, D., Ayrton, A., Morgan, P., Wolf, R.C. and Friedberg, T., 2002. Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. Biochemical Pharmacology 64: 1569-1578.
23. Grove, J.F. and Pople, M., 1980. The insecticidal activity of beauvericin and the enniatin complex. Mycopathologia 70: 103-105.
24. Hidalgo, I.J., Raub, T.J. and Borchardt, R.T., 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96: 736-749.
25. Hiraga, K., Yamamoto, S., Fukuda, H., Hamanaka, N. and Oda, K., 2005. Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. Biochemical and Biophysical Research Communications 328: 1119-1125. (Pubitemid 40238750)
26. Hunter, J. and Hirst, B.H., 1997. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Advanced Drug Delivery Reviews 25: 129-157.
27. Ivanova, L. and Uhlig, S., 2008. A bioassay for the simultaneous measurement of metabolic activity, membrane integrity, and lysosomal activity in cell cultures. Analytical Biochemistry 379: 16-19.
28. Ivanova, L., Skjerve, E., Eriksen, G.S. and Uhlig, S., 2006. Cytotoxicity of enniatins A, A1, B, B1, B2 and B3 from Fusarium avenaceum. Toxicon 47: 868-876.
29. Jestoi, M., Kokkonen, M. and Uhlig, S., 2009. What about the 'other' Fusarium mycotoxins? World Mycotoxin Journal 2: 181-192.
30. Jestoi, M., Rokka, M., Yli-Mattila, T., Parikka, P., Rizzo, A. and Peltonen, K., 2004. Presence and concentrations of the Fusarium-related mycotoxins beauvericin, enniatins and moniliformin in Finnish grain samples. Food Additives and Contaminants 21: 794-802.
31. Kamyar, M., Rawnduzi, P., Studenik, C.R., Kouri, K. and Lemmens- Gruber, R., 2004. Investigation of the electrophysiological properties of enniatins. Archives of Biochemistry and Biophysics 429: 215-223.
32. Litman, T., Druley, T.E., Stein, W.D. and Bates, S.E., 2001. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cellular and Molecular Life Sciences 58: 931-959.
33. Liu, X.L., Tee, H.W. and Go, M.L., 2008. Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein. Bioorganic and Medicinal Chemistry 16: 171-180.
34. Logrieco, A., Rizzo, A., Ferracane, R. and Ritieni, A., 2002. Occurrence of beauvericin and enniatins in wheat affected by Fusarium avenaceum head blight. Applied and Environmental Microbiology 68: 82-85.
35. Maubon, N., Le Vee, M., Fossati, L., Audry, M., Le Ferrec, E., Bolze, S. and Fardel, O., 2007. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundamental & Clinical Pharmacology 21: 659-663.
36. Pavec, P., Merino, G., Wagenaar, E., Bolscher, E., Novotna, M., Jonker, J.W. and Schinkel, A.H., 2005. Human breast cancer resistance protein: interaction with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazol(4,5-b)pyridine, and transport of cimetidine. The Journal of Pharmacology and Experimental Therapeutics 312: 144-152.
37. Pastan, I., Gottesman, M.M., Ueda, K., Lovelace, E., Rutherford, A.V. and Willingham, M.C., 1988. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proceedings of the National Academy of Sciences of the USA 85: 4486-4490.
38. Pohjala, L., Tammela, P., Samanta, S.K., Yli-Kauhaluoma, J. and Vuorela, P., 2007. Assessing the data quality in predictive toxicology using a panel of cell lines and cytotoxicity assays. Analytical Biochemistry 362: 221-228.
39. Prime-Chapman, H.M., Fearn, R.A., Cooper, A.E., Moore, V. and Hirst, B.H., 2004. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. The Journal of Pharmacology and Experimental Therapeutics 311: 476-484.
40. Rabindran, S.K., Ross, D.D., Doyle, L.A., Yang, W. and Greenberger, L.M., 2000. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Research 60: 47-50.
41. Sarkadi, B., Homolya, L., Szakács, G. and Váradi, A., 2006. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiological Reviews 86: 1179-1236.
42. Schinkel, A.H. and Jonker, J.W. 2003. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Advanced Drug Delivery Reviews 55: 3-29.
43. Seithel, A., Karlsson, J., Hilgendorf, C., Björquist, A. and Ungell, A.L., 2006. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. European Journal of Pharmaceutical Sciences 28: 291-299.
44. Sergent, T., Ribonnet, L., Kolosova, A., Garsou, S., Schaut, A., De Saeger, S., Van Peteghem, C., Larondelle, Y., Pussemier, L. and Schneider, Y.J., 2008. Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food and Chemical Toxicology 46: 813-841
45. Steinrauf, L., 1985. Beauvericin and the other enniatins. In: Sigel, H. (ed.) Metal ions in biological systems, volume 19. Marcel Dekker, New York, NY, USA, pp. 139-171.
46. Strongman, D.B., Strunz, G.M., Giguere, P., Yu, C.M. and Calhoun, L., 1988. Enniatins from Fusarium avenaceum isolated from balsam fir foliage and their toxicity to spruce budworm larvae, Choristoneura fumiferana (Clem.) (Lepidoptera: Tortricidae). Journal of Chemical Ecology 14: 753-764.
47. Takano, M., Yumoto, R. and Murakami, T., 2006. Expression and function of efflux drug transporters in the intestine. Pharmacology and Therapeutics 109: 137-161.
48. Tang, F., Horie, K. and Borchardt, R.T., 2002a. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? Pharmaceutical Research 19: 773-779. (Pubitemid 34686735)
49. Tang, F., Horie, K. and Borchardt, R.T., 2002b. Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa? Pharmaceutical Research 19: 765-772. (Pubitemid 34686734)
50. Tep, J., Videmann, B., Mazallon, M., Balleydier, S., Cavret, S. and Lecoeur, S., 2007. Transepithelial transport of fusariotoxin nivalenol: mediation of secretion by ABC transporters. Toxicology Letters 170: 248-258.
51. Uhlig, S., Gutleb, A.C., Thrane, U. and Flåøyen, A., 2005. Identification of cytotoxic principles from Fusarium avenaceum using bioassay-guided fractionation. Toxicon 46: 150-159
52. Uhlig, S., Jestoi, M. and Parikka, P., 2007. Fusarium avenaceum: the North European situation. International Journal of Food Microbiology 119: 17-24.
53. Videmann, B., Tep, J., Cavret, S. and Lecoeur, S., 2007. Epithelial transport of deoxynivalenol: involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food and Chemical Toxicology 45: 1938-1947.
54. Wilson, G., Hassan, I.F., Dix, C.J., Williamson, I., Shah, R., Mackay, M. and Artursson, P., 1990. Transport and permeability properties of human Caco-2 cells: an in vitro model of the intestinal epithelial cell barrier. Journal of Controlled Release 11: 25-40. (Pubitemid 20070083)
55. Wang, Q., Strab, R., Kardos, P., Ferguson, C., Li, J., Owen, A. and Hidalgo, I.J., 2008. Application and limitation of inhibitors in drug-transporter interactions studies. International Journal of Pharmaceutics 356: 12-18.
56. Wätjen, W., Debbab, A., Hohlfeld, A., Chovolou, Y., Kampkötter, A., Edrada, R.A., Ebel, R., Hakiki, A., Mosaddak, M., Totzke, F., Kubbutat, M.H.G. and Proksch, P., 2009. Enniatins A1, B and B1 from an endophytic strain of Fusarium tricinctum induce apoptotic cell death in H4IIE hepatoma cells accompanied by inhibition of ERK phosphorylation. Molecular Nutrition and Food Research 53: 431-440.
57. Xia, C.Q., Milton, M.N. and Gan, L.S., 2007. Evaluation of drug-transporter interactions using in vitro and in vivo models. Current Drug Metabolism 8: 341-363.
58. Zeng, H., Lin, Z.P. and Sartorelli, A.C., 2004. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06. Biochemical Pharmacology 68: 911-921.
59. Zhang, Y., Bachmeier, G. and Miller, D.W., 2003. In vitro and in vivo models for assessing drug efflux transporter activity. Advanced Drug Delivery Reviews 55: 31-51.